Objectives: In a trial completed in 2010, US patients with diabetes and depression were randomized to usual care or telephone cognitive behavioural therapy that emphasized physical activity. Twelve-month intervention effects were observed for blood pressure, depression, and pedometer-measured step-counts. This study examined variation in intervention effects across patient subgroups defined by a measure of clinical complexity. Methods: Three groups of patients were identified at baseline using the Vector Model of Complexity that recognizes socioeconomic, biological, behavioural, and other determinants of treatment response. Complexity-by-intervention interactions were examined using regression models. Results: Intervention effects for blood pressure, depression, and step-counts differed across complexity levels (each p < 0.01). Effects on Beck Depression Inventory scores were greater in the low-complexity group (À8.8) than in the medium-(À3.2) or high-complexity groups (À2.7). Physical activity effects also were greatest in the low-complexity group (increase of 1498 steps per day). In contrast, systolic blood pressure effects were greater among intervention patients with high complexity (À8.5 mmHg). Conclusions: This intervention had varying impacts on physical and mental health depending on patients' clinical complexity. Physical activity and depressive symptom gains may be more likely among less complex patients, although more complex patients may achieve cardiovascular benefits through decreased blood pressures.
Introduction
Depression is a common comorbidity for patients with diabetes, and patients with diabetes plus depression (DMD) have poorer diabetes outcomes than other diabetes patients. [1] [2] [3] [4] [5] [6] Self-care behaviours, including physical activity, have been clearly linked to depressive symptomatology. [7] [8] [9] [10] [11] Cognitive behavioural therapy (CBT) may be a particularly useful approach to improving outcomes for DMD patients, because CBT can treat patients' depressive symptoms directly as well as address the diabetesspecific cognitions that are important mediators of effective self-management. 12 These collateral benefits of CBT are particularly important, since diabetes-related distress may be one of the correlates of depressive symptoms that is most directly related to poor glycaemic control. 13 Given the myriad of short-term and long-term management goals for DMD patients, interventions may be especially beneficial when they focus on behaviours that influence both patients' mood as well as their risk for micro-and macrovascular complications. Physical activity is an important behavioural target because it can improve patients' depressive symptoms, glycaemic control, and other cardiovascular risk factors. 12, [14] [15] [16] [17] [18] [19] [20] Another advantage of physical activity focused interventions is that pedometers can be a behavioural motivator and also provide an objective measure for gauging the impact of the programme. 21 The 'Positive Steps Study' is a recently completed, multi-site randomized trial comparing the outcomes of enhanced usual care to a telephone-based programme of CBT that emphasized the links between depression and diabetes as well as the promotion of physical activity. A separate paper 22 reports that among participants the mean baseline level for A1c (the primary outcome for the trial) was 7.6%, and there was no notable differences in A1c across groups at 12 months. However, the intervention had statistically significant positive impacts at 12 months on patients' systolic blood pressures (mean relative reduction of 4.26 mmHg), depressive symptoms as measured by the Beck Depression Inventory (BDI, mean relative reduction of 4.5 points), and pedometermeasured step-counts (mean relative increase of 1131 steps per day; all p < 0.05).
While these average intervention effects are encouraging, the benefits of this intervention may not have been experienced equally across all patients in the study. In particular, patients' clinical complexity may affect their ability to make behavioural changes or benefit physiologically from the intervention. Complexity is a multidimensional construct, reflecting the socioeconomic, cultural, biological, environmental, and behavioural characteristics that can interact with patients' treatment and determine outcomes. 23, 24 Evidence suggests that outcomes of diabetes management can be influenced by comorbidities and other factors that increase complexity. [25] [26] [27] A complexity measure may be useful for identifying subgroups of clinical trial participants who are more or less likely to benefit than average. However, researchers often evaluate variation in intervention effects by creating multiple subgroups defined by baseline levels of each outcome, as well as potentially arbitrary patient characteristics such as age, gender, and race. Hayward et al. 28 have pointed out that this approach capitalizes on chance variations, complicates interpretability (i.e. because patients are differently distributed across groups for each analysis) and could obscure important intervention benefits among patients with the greatest overall need for additional services. Subgroup analysis based on a multidimensional complexity score avoids these problems and may uncover groups most likely to benefit from a new programme, while providing clues regarding mechanisms of intervention effect.
The purpose of this study was to reexamine differences in effects on outcomes (blood pressure, depressive symptoms, physical activity, and A1c) among participants in the Positive Steps Study across groups representing varying levels of clinical complexity at the time of entry into the trial.
Methods

Overview of the design
This was a secondary analysis of data collected as part of the Positive Steps Study. In brief, patients with DMD were randomized to enhanced usual care or telephone CBT which emphasized the links between depression and diabetes as well as a physical activity programme with pedometers. Endpoints, including A1c, blood pressure, depression scores, and pedometer-measured step-counts were measured at 12 months post enrolment. Detailed methods are described elsewhere 22 and summarized below.
Recruitment and randomization
Adult participants with diabetes using antihyperglycaemic medication were identified from a community-based non-profit healthcare system, a university healthcare system, and a VA healthcare system. Patients were ineligible if at the time of telephone screening they had a Patient Health Questionnaire-9 (PHQ-9) 29 depression score of <11, had been diagnosed with bipolar disorder or schizophrenia, were diagnosed with diabetes before age 15 and only using insulin (i.e. likely type 1 patients), or were in active treatment for another life-threatening condition. Additional patients were excluded if they reported a recent change in their depression management or that they were unable to walk either one block or 10 min without rest.
Eligible patients were invited to an inperson screening and recruitment visit. Patients were excluded if: they had a BDI 30 score <14, they scored <21 on the Short Orientation Memory Concentration Test, 31 or they reported active drug or alcohol abuse using the CAGE questionnaire. 32 All patients completed a written informed consent. The study was approved by the IRB in each of the three participating healthcare systems. Enrolled patients were randomized with equal probability to either the intervention or usual care using sealed opaque envelopes and a table of random numbers.
Intervention
Intervention patients participated in a 12month telephone CBT programme delivered by registered nurses with a mix of psychiatric and primary care training. The CBT programme included an initial intensive phase of 12-weekly sessions followed by 9-monthly booster sessions. At first, CBT focused exclusively on patients' depressive symptoms; after five sessions, nurse counsellors introduced concepts related to a pedometer-based walking programme, and the links between depression, physical activity, and diabetes outcomes.
Prior to initiating patient counselling, each nurse participated in an intensive training programme including a six-session CBT course. Nurses also participated in weekly group supervisory sessions, where they discussed problematic cases and shared information about strategies for completing the CBT protocol. Each nurse audio-recorded initial sessions with their patients, and those recordings were reviewed by an experienced CBT supervisor and trainer during group supervision. Both nurses and patients used a week-by-week manual to guide their CBT sessions. Nurse manuals included checklists for each week's CBT goals. During each session, nurses monitored patients' depressive symptoms using the PHQ and monitored their activity levels using the PASE. 29, 33 Patient manuals included logs that patients could use to complete CBT homework exercises and to monitor their progress towards step-count goals.
Enhanced usual care
Usual care patients received: a copy of the Feeling Good Handbook-a self-help book based on CBT for depression, 34 National Institute of Mental Health educational materials about depression, educational materials about walking and diabetes, and a list of local resources for depression. If usual care patients allowed, their primary care physician was notified about their depression scores.
Measurement
Patients completed in-person interviews at baseline and 12 months. Interviews were conducted by trained, non-clinical research assistants. At both time points, their A1c was measured using the DCA2000 Õ point-of-care analyzer. 35 Blood pressure was measured in both arms using an Omron Õ automatic monitor with a repeat measurement in the arm with the highest pressure after several minutes of rest. This third measure was used in study analyses.
Six weeks after completing their baseline assessment, all patients were sent an Omron Õ HJ-720 ITC pedometer. Pedometers were sent blinded using a removable sticker, and patients were instructed to wear the pedometer throughout waking hours for seven consecutive days. At the end of the week, patients were instructed to remove the sticker and contact the study team to report their step-counts. Those who did not call the team were contacted by research staff. Controlgroup patients then returned the pedometer; intervention patients were instructed to keep the pedometer for use in their walking programme. At the 12-month follow-up, all control patients as well as intervention patients who had lost their pedometer were again sent a blinded pedometer with similar instructions.
The main depression measure was the BDI. 30 Perceived self-efficacy for physical activity and diet were measured using the Perceived Competence Scale. 36, 37 Adherence to antihyperglycaemic medication was measured using the Morisky medication adherence scale. 38 
Baseline complexity levels
Patients' clinical complexity at baseline was measured using the Vector Control Model of Complexity. 23 Much like the Andersen and Aday model for treatment access, 39 the Vector model articulates dimensions of complexity that can be measured differently depending on the specific purpose of the study and available data. In this study, we used the following indicators for each dimension of complexity: socioeconomic: age 75 or higher, high school education or less, annual income $10,000 or less; culture: non-white race or Hispanic ethnicity; biologic/genetic: body mass index of 40 or higher (class III obesity), high A1c (i.e. 8.0% or higher if the patient was less than 65 years of age and 8.5% or higher if age 65 or older), systolic blood pressure 140 mmHg or higher (indicating uncontrolled hypertension), BDI depression score greater than 28 (indicating moderate or severe depression); environmental/ecological: no spouse or other partner; behavioural: diabetes medication adherence score greater than 2 on the Morisky scale, 38 no evidence of at least moderate physical activity (less than 2000 pedometer steps per day or missing baseline pedometer data), dietary and activity-related self-efficacy in the lowest quartile of the distribution on the Perceived Competence Scale. 36, 37 Patients received 1 point for each indicator. The resulting score ranged from 0-12 and was collapsed into three roughly equal groups based on tertiles of the distribution representing low-complexity (scores of 0 or 1), medium-complexity (scores of 2-3), and high-complexity (4þ) patients.
Analysis
This study was based on new models of complexity emerging since the trial's design as well as feedback from intervention nurses regarding the role of comorbidity as an impediment to patients' ability to respond to the new service provided. As such, the hypothesis tested was not planned a priori and the results are exploratory.
In initial analyses, variation in patients' baseline characteristics was examined across complexity levels and then across experimental groups within complexity levels. Outcomes of interest included the primary outcome for the trial (A1c), and secondary outcomes that were shown to have an overall average intervention effect (systolic blood pressure, BDI depression score, and stepcounts). To identify potential complexity-byintervention interactions, regression models were fit predicting each endpoint value controlling for baseline values. Those models included terms designed to identify variation in intervention effects across complexity subgroups by including dummy variables for combinations of complexity group and treatment arm (i.e. medium complexity þ control, high complexity þ control, low complexity þ intervention, medium complexity þ intervention, and high complexity þ intervention). Post-fitting statistical tests compared the magnitude of estimated coefficients for intervention effects within complexity levels in order to identify significant intervention/control differences within strata. A global statistical test was conducted to identify an overall variation in intervention effects across complexity levels. These models and baseline values for each outcome within the three complexity levels were used to calculate predicted post-intervention values controlling for baseline differences and secular trends. Finally, regression models were re-calculated after converting each outcome to a z-score so that the varying patterns in the relationship between receipt of the intervention and complexity could be illustrated graphically.
Results
Baseline characteristics of the sample
A total of 5542 patients were identified from electronic records, of which 474 (8.6%) were found to be [potentially] eligible during telephone screening. Of those patients, 51 did not attend the in-person eligibility screening and 84 were found to be ineligible at that subsequent screening. The remaining 339 patients were enrolled in the trial, of whom 291 (86%) provided A1c, blood pressure, and survey data at the 12-month follow-up. Patients who failed to provide these follow-up data were similar on a large number of measures (including all outcomes presented here) but were somewhat more satisfied at baseline with their healthcare (p < 0.05). Of those providing in-person follow-up data, 214 (74%) provided both baseline and followup pedometer data. Those without stepcount data had lower incomes, higher systolic blood pressures, and higher (i.e. worse) BDI scores at baseline.
For the overall sample, there were no significant differences at baseline in intervention and control patients' sociodemographic characteristics, A1c's, blood pressures, depressive symptoms, or surveybased outcomes. Patients' mean age was 56 years, half were women, and 84% were White. The mean baseline A1c in the overall sample was 7.6% (SD: 1.7).
When classifying patients according to baseline complexity level, 25% of the sample was classified as low complexity, 40% as medium complexity, and 35% as high complexity. Individual health and behavioural risk factors varied systematically across complexity levels ( Table 1) . As expected, highcomplexity patients were very sedentary, with 73.5% having an average of less than 2000 steps per day (as compared to the lowcomplexity group with only 11.1% this sedentary). Moreover, more than half of high-complexity patients had: BMIs >40, systolic blood pressures >140 mmHg, BDI depression scores >28, no spousal partner, and low diabetes self-care self-efficacy scores. Baseline values for each outcome were similar across treatment groups within complexity strata ( Table 2 ).
Variation in intervention effects across complexity levels
Heterogeneity of treatment effect across complexity levels was not detected for the trial's primary outcome, A1c, but was detected for the three secondary outcomes that showed a significant main treatment effects: systolic blood pressure, step-counts, and BDI depression scores ( Table 3) . Regression models identified large and statistically significant intervention effects on systolic blood pressure among high-complexity patients, but not among lowcomplexity patients. An isolated reduction in diastolic blood pressures that was not found in the main trial analysis was identified in the high-complexity group. In contrast, the largest impacts on step-counts and In MANOVA models including terms for randomization group and complexity level, intervention groups were significantly different with respect to systolic BP, diastolic BP, step-counts, and BDI. Predicted endpoint values were calculated based on regression models that controlled for differences in baseline values and secular trends. BDI scores were observed in the lowestcomplexity stratum. The figure illustrates the significant variation in effects across complexity strata (Figure 1 ).
Discussion
In this randomized trial with overall intervention effects on DMD patients' systolic blood pressures, pedometer-measured stepcounts, and BDI depression scores, we found that those effects varied significantly depending on the patient's clinical complexity upon entry into the trial. Specifically, depressive symptoms and physical activity levels improved the most in the low-complexity group, while the overall average improvement in systolic blood pressure was driven by improvements in pressures among the most complex intervention participants. The association between decreased depressive symptoms and increased step-counts for low complexity patients likely reflects multiple, reciprocal processes. Cross-sectional studies show that depressive symptoms and activity levels correlate. 40 Lack of motivation and sedentary behaviour are common symptoms of depression and improvements in mood would be expected to increase physical activity. 41 On the other hand, depression interventions are less effective in increasing physical activity, 42 in part because effective depression treatment often neglects behavioural strategies for physical activity reinforcement.
Among both medium-and high-complexity patients, we found that step-count increases were modest. This lack of response to the walking component of the intervention is disappointing, but perhaps not surprising. Maintaining a physical activity programme over the course of a year is difficult for most people, 43 and is particularly difficult for those with multiple comorbidities, very high BMIs, and other factors contributing to clinical complexity. Older individuals frequently list medical problems as the primary barrier to participation in physical activity programmes. 44 This pedometer-based walking programme was designed specifically for multi-morbid patients 45 and such programmes have been found to be effective for patients with a variety of chronic conditions. 46-48 However, Figure 1 . Variation in standardized effect scores across complexity levels. Positive standardized scores for each outcome represent improvements in health. BDI depression scores decreased the most among intervention patients in the low-complexity group while step-counts increased the most in that group. In contrast, systolic blood pressures decreased the most in the high-complexity group.
this study suggests that among patients who all have at minimum two serious comorbid chronic diseases (i.e. DMD), relatively complex patients may face such serious physical barriers to walking (e.g. pain and deconditioning) that more intensive clinician-guided interventions are required. 25, 49 It is unclear why high complexity patients experienced a substantial improvement in their systolic blood pressures, despite relatively small improvements in physical activity and depression scores. Of course, because patients in this group had relatively high pressures at baseline, one might expect more improvement; however, this same pattern was not observed for step-counts or BDI depression scores. The two most direct strategies for improving blood pressures are ensuring that patients are prescribed the appropriate pharmacotherapy and that they take those medications as prescribed. Unfortunately, this study did not collect data specifically on antihypertensive regimen changes or medication adherence. Given the large impacts on systolic pressures observed and the clinical importance of such improvements in hypertension management, future studies should explore similar interventions for complex patients as well as the mechanisms of action for treatment effects.
As with any secondary analysis of randomized trial results, these findings are exploratory. Patients were not randomized within complexity levels and the study was not powered a priori for testing interventioncontrol differences within those levels. Although baseline intervention-control differences were small within complexity strata and baseline values were controlled for in all outcome analyses, it is possible that unmeasured differences in baseline health status across groups could affect the result reported here. In the USA, the majority of people who receive a clinical diagnosis of diabetes are put on antihyperglycaemic medication either at the time of diagnosis or within the subsequent 6 months. This study applies only to that population. It should be noted that physical activity also is an important behaviour for improving cardiovascular health and preventing conversion to diabetes among pre-diabetic patients. 50 Finally, as with all subgroup analyses, multiple comparisons may contribute to the findings and they should be interpreted as hypothesis generating rather than definitive.
Conclusions
In sum, we found significant heterogeneity of treatment effects for the Positive Steps intervention according to patients' baseline complexity levels. The least complex patients benefited the most with respect to their depression and physical inactivity, while more complex patients experienced significant improvements in their systolic blood pressures, despite less improvement in these former two outcomes. While telehealth management interventions such as this can improve blood pressures among highly complex patients, more intensive interventions may be required to address those patients' persistent depressive symptoms and very low levels of physical activity. Complexity represents a broad array of determinants, and capturing those data through systematic assessment or clinical interview could be useful in tailoring interventions to patients most likely to benefit. For researchers, analysing trial results according to a priori subgroups that vary in terms of clinical complexity could ensure that important intervention benefits are not missed in overall average effects driven by a large number of programme participants who may not respond to treatment. Novel services for patients with diabetes and other chronic conditions should move beyond the 'onesize-fits-all approach' in order to develop a portfolio of evidence-based options that fit with patients' needs, resources, and preferences. 51 
